Today after market close, we released our unaudited results for the fourth quarter and fiscal year 2026, which are posted along with our earnings call presentation to our Investor Relations website at ...
Extends the budget period for the ~$2M total NIH grant funding award for DARE-PTB1 through November 2026• DARE-PTB1 targets preterm birth, for which there are no FDA-approved treatment options• Award ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results